Lisinopril/HCTZ
- Product NDC
- 72189-651
- 11-digit product format
- 721890651
- Labeler code
- 72189
- Product ID
- 72189-651_4510c108-2684-f505-e063-6394a90ab0a4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril/HCTZ
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA076230
- Marketing category
- ANDA
- Marketing start
- 2025-12-03
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 12.5; 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72189-651-30 | 72189065130 | 30 TABLET in 1 BOTTLE (72189-651-30) | 30 tablet | 2025-12-03 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Lisinopril/HCTZ | Direct_Rx | 2025-12-03 | HUMAN PRESCRIPTION DRUG LABEL | 1 |